- Trials with a EudraCT protocol (307)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
307 result(s) found for: Metabolic Processes.
Displaying page 1 of 16.
EudraCT Number: 2016-001661-91 | Sponsor Protocol Number: ML19569 | Start Date*: 2016-12-09 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche AG | ||||||||||||||||||
Full Title: Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents | ||||||||||||||||||
Medical condition: Obesity in combination with metabolic disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000432-26 | Sponsor Protocol Number: versie1,dd01-02-2012 | Start Date*: 2012-09-26 |
Sponsor Name:Maastricht University Medical Centre | ||
Full Title: Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome | ||
Medical condition: Kabuki Syndrome (KS, OMIM 147920) with a mutation in MLL2 gene. | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002037-38 | Sponsor Protocol Number: NL44415.078.13 | Start Date*: 2013-10-29 |
Sponsor Name: | ||
Full Title: The effect of correction of metabolic acidosis in chronics kidney disease on intrarenal RAS activity. | ||
Medical condition: Metabolic acidosis in chronic kidney disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000199-86 | Sponsor Protocol Number: 2015-000199-86 | Start Date*: 2015-04-29 | ||||||||||||||||
Sponsor Name:University of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, section of Metabolic Genetic | ||||||||||||||||||
Full Title: Effects of metformin on human gut microbiota | ||||||||||||||||||
Medical condition: Young healthy men | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000677-77 | Sponsor Protocol Number: S61338 | Start Date*: 2018-06-26 |
Sponsor Name:University Hospital Leuven | ||
Full Title: Novel strategies in weight loss in women with polycystic ovary syndrome: does the gut microbiome play a role? | ||
Medical condition: overweight and obese women with polycystic ovary syndrome (PCOS) at risk for metabolic syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001850-16 | Sponsor Protocol Number: 2016-001850-16 | Start Date*: 2016-06-28 | |||||||||||
Sponsor Name:University of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, Section of Metabolic Genetic | |||||||||||||
Full Title: Studies of interplays between insulin resistance associated with immunosuppression and the gut and saliva microbiota composition of young, healthy men | |||||||||||||
Medical condition: Young healthy men | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002638-36 | Sponsor Protocol Number: 1aa | Start Date*: 2020-03-03 |
Sponsor Name:Bispebjerg Hospital, University of Copenhagen | ||
Full Title: Glucagon Dose-response Relationship for Cardiovascular Activity A Randomized, participant-blinded, Crossover Study | ||
Medical condition: Glucagon-induced changes in heart rate, blood pressure, cardiac output. and metabolic effects | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-004846-25 | Sponsor Protocol Number: Pfizer-Prevenar13-2015 | Start Date*: 2016-07-15 |
Sponsor Name:Maastricht University | ||
Full Title: Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders | ||
Medical condition: Familial hypercholesterolemia Niemann-Pick disease type B (NPB) Niemann-Pick disease type C (NPC) Partial lipodystrophy in children and adults | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002220-32 | Sponsor Protocol Number: 225/2611 | Start Date*: 2012-06-13 |
Sponsor Name:OYS | ||
Full Title: The effects of contraceptive pill and hormonal vaginal ring on hormonal, inflammatory and metabolic parameters in women of reproductive age with polycystic ovary syndrome (PCOS). | ||
Medical condition: Polycystic Ovary Syndrome (PCOS) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003910-26 | Sponsor Protocol Number: 01/2015 | Start Date*: 2017-12-11 |
Sponsor Name:Núcleo de Estudos de Hipertensão da Beira Interior | ||
Full Title: Fase II, unicenter, open, randomized trial to evaluate the response of Th17 and T regulatory lymphocytes to 24 weeks supplementation with cholecalciferol in patients with arterial hypertension, obe... | ||
Medical condition: Obesity associated arterial hypertension Metabolic syndrome associated arterial hypertension | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: PT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004755-21 | Sponsor Protocol Number: CHUBX2012/17 | Start Date*: 2016-03-15 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Multicenter double-blind randomized clinical trial assessing efficacy and safety of exenatide in the treatment of hypothalamic obesity after craniopharyngioma therapy. | ||
Medical condition: Hypothalamic obesity after craniopharyngioma therapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003430-85 | Sponsor Protocol Number: OBERAL | Start Date*: 2017-11-29 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: A randomized, open, parallel design study to evaluate the effect on liver fat, adipose tissue and metabolic parameters when switching a protease inhibitor or efavirenz to once daily raltegravir in ... | ||
Medical condition: Study subjects are HIV infected patients with BMI>25kg/m2 and who have at least one metabolic syndrome component or a fatty liver disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004782-14 | Sponsor Protocol Number: THIGHT_2 | Start Date*: 2014-03-20 |
Sponsor Name:Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel | ||
Full Title: Assessment of changes in metabolic activity in liver & skeletal muscle in patients suffering from acromegaly - a 31P/1H magnetic resonance spectroscopy pilot study | ||
Medical condition: Acromegaly | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002987-26 | Sponsor Protocol Number: KOLterbutaline | Start Date*: 2011-08-24 |
Sponsor Name:Bispebjerg Hospital | ||
Full Title: Effects of high dose terbutaline on physical performance in patients with chronic obstructive pulmonary disease and acute inflammatory response after exercise | ||
Medical condition: To investigate the effects of terbutaline on repeated exercise performance in patients with chronic obstructive pulmonary disease (COPD). Furthermore to examine the inflammatory response during and... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000404-35 | Sponsor Protocol Number: 80519 | Start Date*: 2022-07-26 |
Sponsor Name:AMC, Cardiovascular Sciences | ||
Full Title: Does the hematopoietic stem cell govern residual inflammatory cardiovascular risk in type 2 diabetes? | ||
Medical condition: Inflammation in patients with type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000152-19 | Sponsor Protocol Number: 1 | Start Date*: 2022-02-24 |
Sponsor Name:Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) | ||
Full Title: Control strategies and pharmacogenetic study for the personalized treatment of fatty liver associated with metabolic dysfunction in patients with prediabetes. | ||
Medical condition: Metabolic Associated Fatty Liver Disease with prediabetes. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003823-14 | Sponsor Protocol Number: CDCA-PK | Start Date*: 2021-11-16 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Pharmacokinetic cross-over study of compounded chenodeoxycholic acid. | ||
Medical condition: CTXCT | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003566-13 | Sponsor Protocol Number: GLP1-hypofyse | Start Date*: 2019-01-02 |
Sponsor Name:Radboud university medical center | ||
Full Title: iPAVE – imaging Pituitary ActiVation by Exendin | ||
Medical condition: Type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004123-19 | Sponsor Protocol Number: MUN-391-LOR-0050-I | Start Date*: 2006-01-24 |
Sponsor Name:Klinikum rechts der Isar der Technischen Universitaet Muenchen | ||
Full Title: Metabolic Response Evaluation for an Individualization of Neoadjuvant Chemo- and Radiotherapy in Esophageal Adenocarcinoma | ||
Medical condition: This study will test an optimized therapy for patients with chemotherapy-resistent locally advanced adenocarcinomas at the gastro-esophageal junction. According to the protocol, patients should re... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005404-17 | Sponsor Protocol Number: TAO-EX-2012 | Start Date*: 2013-01-16 |
Sponsor Name:Center for Neuropsychiatric Schizophrenia Research | ||
Full Title: Treatment of antipsychotic associated obesity with a GLP-1 Analogue: the TAO study | ||
Medical condition: Obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.